Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
Capsules1.5 mg
Similar Products
RIVASTIGMINA ARENA 1.5 mg
Cholinesterase inhibitor indicated in the treatment of Alzheimer's type dementia
Active Substance (INN)
RIVASTIGMINUM
Packaging
3,4,11 bl x 10 caps
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.